Current Research in Translational Medicine

Papers
(The TQCC of Current Research in Translational Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Caspases in PANoptosis42
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations24
Editorial Board22
Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation17
Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?14
Clinical features and functions of a novel Lpl mutation C.986A>C (p.Y329S) in patient with hypertriglyceridemia13
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type11
Post-herpetic encephalitis cerebral abscess: Viral reactivation or latency site within central nervous system?11
Contents10
Coexistence of three hematological malignancies in association with a first time documented mutation: “One train can hide another”°, and even more!9
Management of Philadelphia chromosome positive acute lymphoblastic leukemia in the current era8
APOE ε4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain8
Performances of the H-score and the HLH-2004 score in the positive diagnosis of secondary hemophagocytic lymphohistiocytosis8
Cytogenetics in the management of hematological malignancies: Guidelines from the Groupe Francophone de Cytogénétique Hématologique8
Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)8
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia8
Dermatological manifestations as a first sign of Erdheim-Chester Disease: A case report8
Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFC8
Expression and survival analysis of the STAT gene family in diffuse gliomas using integrated bioinformatics8
Validation of analytical methods for the production of expanded γδ T lymphocytes useful for therapeutic purposes7
Genetic diversity and expression profile of Plasmodium falciparum Pf34 gene supports its immunogenicity7
Astaxanthin attenuates acute cerebral infarction via Nrf-2/HO-1 pathway in rats7
Gene signatures and prognostic values of m6A-related genes in multiple myeloma7
CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma6
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge6
In vitro blood brain barrier models: Molecular aspects and therapeutic strategies in glioma management6
Bone marrow alterations in COVID-19 infection: The root of hematological problems6
Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation5
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura5
Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial5
In vivo and in vitro effects of cord blood hematopoietic stem and progenitor cell (HSPC) expansion using valproic acid and/or nicotinamide5
CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review5
Editorial Board4
Pectins from various sources inhibit galectin-3-related cardiac fibrosis4
A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER24
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans4
Editorial board4
Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): An international survey of contemporary practice4
Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)4
Exhaled breath condensate proteomic signatures potentially distinguish adenocarcinoma from benign cystic lesions of the pancreas3
Contents3
Early prediction of renal graft function: Analysis of a multi-center, multi-level data set3
Preclinical study of a DNA vaccine targeting SARS-CoV-23
The use of intrathecal chemotherapy and dexamethasone for secondary prevention of blinatumomab-related neurotoxicity3
Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy3
Introduction to medical data and big data exploitation in research: Errors, solutions and trends3
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience3
Pyroptosis in sepsis induced organ dysfunction3
Adjusting diffusing capacity for anemia in patients undergoing allogeneic HCT: a comparison of two methodologies3
A simple score (Biovid-19) based on biological parameters predicts transfer to intensive care units and death in COVID-19 patients3
Editorial board3
Association of Normal and Mutated APOL1 G2 Rs60910145 alleles with SCD, Body Mass Index, and Renal Function Biomarkers and Indices3
Thoughts on cartilage tissue engineering: A 21st century perspective3
A novel MPIG6B gene mutation in an adolescent girl with congenital thrombocytopenia and myelofibrosis3
0.035067081451416